Last update 21 Nov 2024

Respiratory Syncytial Virus Vaccine (maxvax)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Genetically engineered subunit vaccine
Synonyms
重组呼吸道合胞病毒疫苗（CHO细胞）(成都华任康)
Target-
Mechanism-
Therapeutic Areas
Infectious Diseases
Active Indication
Respiratory Syncytial Virus Infections
Inactive Indication-
Originator Organization
Chengdu Huarenkang Biotechnology Co., Ltd.
Active Organization
Chengdu Maxvax Biotechnology LLCChengdu Maxvax Biotechnology LLCStartup
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Respiratory Syncytial Virus Vaccine (maxvax)
CTR20243803 / RecruitingPhase 1/2
单中心、随机、双盲、安慰剂对照设计评价重组呼吸道合胞病毒疫苗（CHO细胞）在18周岁及以上人群中接种的安全性、免疫原性的Ⅰ/II期临床试验
[Translation] A single-center, randomized, double-blind, placebo-controlled Phase I/II clinical trial to evaluate the safety and immunogenicity of a recombinant respiratory syncytial virus vaccine (CHO cells) in people aged 18 years and above
NCT06642558 / RecruitingPhase 1/2
A Phase I/II, Single Center, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above
100 Clinical Results associated with Respiratory Syncytial Virus Vaccine (maxvax)
Login to view more data
100 Translational Medicine associated with Respiratory Syncytial Virus Vaccine (maxvax)
Login to view more data
100 Patents (Medical) associated with Respiratory Syncytial Virus Vaccine (maxvax)
Login to view more data
100 Deals associated with Respiratory Syncytial Virus Vaccine (maxvax)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Respiratory Syncytial Virus InfectionsPhase 2
CN
Chengdu Maxvax Biotechnology LLCChengdu Maxvax Biotechnology LLCStartup
13 Nov 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free